FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

FusionGeneSummary

leaf

FusionProtFeature

leaf

FusionGeneSequence

leaf

FusionGenePPI

leaf

RelatedDrugs

leaf

RelatedDiseases

Fusion gene ID: 20814

FusionGeneSummary for MAP2K4_PSMD12

check button Fusion gene summary
Fusion gene informationFusion gene name: MAP2K4_PSMD12
Fusion gene ID: 20814
HgeneTgene
Gene symbol

MAP2K4

PSMD12

Gene ID

6416

5718

Gene namemitogen-activated protein kinase kinase 4proteasome 26S subunit, non-ATPase 12
SynonymsJNKK|JNKK1|MAPKK4|MEK4|MKK4|PRKMK4|SAPKK-1|SAPKK1|SEK1|SERK1|SKK1Rpn5|STISS|p55
Cytomap

17p12

17q24.2

Type of geneprotein-codingprotein-coding
Descriptiondual specificity mitogen-activated protein kinase kinase 4JNK-activated kinase 1JNK-activating kinase 1MAP kinase kinase 4MAPK/ERK kinase 4MAPKK 4MEK 4SAPK/ERK kinase 1c-Jun N-terminal kinase kinase 1stress-activated protein kinase kinase 126S proteasome non-ATPase regulatory subunit 1226S proteasome regulatory subunit RPN526S proteasome regulatory subunit p55proteasome (prosome, macropain) 26S subunit, non-ATPase, 12
Modification date2018052320180523
UniProtAcc

P45985

O00232

Ensembl transtripts involved in fusion geneENST00000353533, ENST00000415385, 
ENST00000581941, 
ENST00000356126, 
ENST00000357146, ENST00000581618, 
Fusion gene scores* DoF score6 X 4 X 5=1206 X 6 X 3=108
# samples 76
** MAII scorelog2(7/120*10)=-0.777607578663552
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/108*10)=-0.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: MAP2K4 [Title/Abstract] AND PSMD12 [Title/Abstract] AND fusion [Title/Abstract]

Functional or gene categories assigned by FusionGDB annotationTumor suppressor gene involved fusion gene, retained protein feature but frameshift.
DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID

check button Fusion gene information from three resources
(ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018))
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
Data typeSourceCancer typeSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
TCGARVHNSCTCGA-RS-A6TP-01AMAP2K4chr17

11924318

+PSMD12chr17

65353694

-
* LD: Li Ding group's fusion gene list
  RV: Roel Verhaak group's fusion gene list
  ChiTaRs fusion database

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shiftENST00000353533ENST00000356126MAP2K4chr17

11924318

+PSMD12chr17

65353694

-
5CDS-intronENST00000353533ENST00000357146MAP2K4chr17

11924318

+PSMD12chr17

65353694

-
5CDS-5UTRENST00000353533ENST00000581618MAP2K4chr17

11924318

+PSMD12chr17

65353694

-
Frame-shiftENST00000415385ENST00000356126MAP2K4chr17

11924318

+PSMD12chr17

65353694

-
5CDS-intronENST00000415385ENST00000357146MAP2K4chr17

11924318

+PSMD12chr17

65353694

-
5CDS-5UTRENST00000415385ENST00000581618MAP2K4chr17

11924318

+PSMD12chr17

65353694

-
intron-3CDSENST00000581941ENST00000356126MAP2K4chr17

11924318

+PSMD12chr17

65353694

-
intron-intronENST00000581941ENST00000357146MAP2K4chr17

11924318

+PSMD12chr17

65353694

-
intron-5UTRENST00000581941ENST00000581618MAP2K4chr17

11924318

+PSMD12chr17

65353694

-

Top

FusionProtFeatures for MAP2K4_PSMD12


check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
MAP2K4

P45985

PSMD12

O00232

Dual specificity protein kinase which acts as anessential component of the MAP kinase signal transduction pathway.Essential component of the stress-activated protein kinase/c-JunN-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7,is the one of the only known kinase to directly activate thestress-activated protein kinase/c-Jun N-terminal kinasesMAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 andMAP2K7/MKK7 both activate the JNKs by phosphorylation, but theydiffer in their preference for the phosphorylation site in theThr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation ofthe Tyr residue and MAP2K7/MKK7 for the Thr residue. Thephosphorylation of the Thr residue by MAP2K7/MKK7 seems to be theprerequisite for JNK activation at least in response toproinflammatory cytokines, while other stimuli activate bothMAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylateJNKs. MAP2K4 is required for maintaining peripheral lymphoidhomeostasis. The MKK/JNK signaling pathway is also involved inmitochondrial death signaling pathway, including the releasecytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7exclusively activates JNKs, MAP2K4/MKK4 additionally activates thep38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.{ECO:0000269|PubMed:7716521}. Component of the 26S proteasome, a multiprotein complexinvolved in the ATP-dependent degradation of ubiquitinatedproteins. This complex plays a key role in the maintenance ofprotein homeostasis by removing misfolded or damaged proteins,which could impair cellular functions, and by removing proteinswhose functions are no longer required. Therefore, the proteasomeparticipates in numerous cellular processes, including cell cycleprogression, apoptosis, or DNA damage repair.{ECO:0000269|PubMed:1317798}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

.

* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

FusionGeneSequence for MAP2K4_PSMD12


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences.
(nt: nucleotides, aa: amino acids)

* Fusion amino acid sequences.

* Fusion transcript sequences (only coding sequence (CDS) region).

* Fusion transcript sequences (Full-length transcript).

Top

FusionGenePPI for MAP2K4_PSMD12


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page

.

check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors
MAP2K4FLNC, SPAG9, MAPK8, MAP4K2, MAP2K7, MAP3K8, AKT1, MAPK8IP3, MAP3K11, MAP3K4, ARRB2, MAP3K2, MAP3K1, NPHS1, ITCH, MAPK9, BLNK, PML, MAPK10, MAP3K5, MAP2K6, MAP2K4, MAPK14, MAP3K3, LRRK2, APP, JUN, MAP3K7, ARRB1, MAPK1, GCH1, GEMIN5, RBBP8, EGFR, MAP3K10, NBR1, KTI12, VASP, FLNB, CDC5L, UBC, TRIM25PSMD12PSMD13, PSMD6, PAAF1, PSMD10, TRAF6, PSMD14, PSMD7, UCHL5, USP14, USP20, RNF185, UBC, INSIG2, EIF3E, PSMD12, EIF3D, PSMC6, CALM1, SHFM1, PCK1, RAD23A, PSMD3, SIRT7, FKBP8, PSMA2, PSMC1, PSMC3, PSMC2, PSMC5, PSMD11, PSMD1, PSMD2, PSMD8, PSMD4, PSMC4, PSMB1, PSMB5, PSMA6, PSMA7, PSMA5, PSMB7, PSMA1, PSMB6, PSMB2, PSMA4, PSMB3, PSMB4, PSME1, PSME3, HDLBP, UGGT1, NOS2, PARK2, NPM1, RNF11, BAG3, HNRNPA0, KIAA0368, FLNB, FLNC, KCMF1, SQSTM1, TXNL1, HUWE1, FUS, RNF2, CCDC74B, CCDC92, ADRM1, PSMB9, AMBRA1, MCM7, NAA15, NAA16, PSMA3, PSMB8, AHCYL1, CAD, COPE, COPS7A, CUL1, IKBKAP, ITGAV, MCFD2, NLRP9, PPID, PSMD9, PSMD5, SGTA, KRAS, SNW1, CDC5L, ENPP1, HMGB2, UBLCP1, EIF3H, EIF3M, STKLD1, EIF3L, EIF3C, KDELR1, TRIM11, INTU, HSD17B10, CCND2, BRCA1


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

RelatedDrugs for MAP2K4_PSMD12


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.0 2018-04-02)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

RelatedDiseases for MAP2K4_PSMD12


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgenePSMD12C0011616Contact Dermatitis1CTD_human